News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Cormorant Asset Management, LP
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/04/2023 |
4
| Chen Bihua (10% Owner) has filed a Form 4 on MoonLake Immunotherapeutics|
Txns:
| Bought 74,911 shares
@ $57.37, valued at
$4.3M
Bought 150,487 shares
@ $57.252, valued at
$8.6M
Bought 67,814 shares
@ $57.3188, valued at
$3.9M
|
|
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2023 |
4
| Chen Bihua (10% Owner) has filed a Form 4 on Biomea Fusion, Inc.|
Txns:
| Granted 6,989 options to buy
@ $38.9, valued at
$271.9k
|
|
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/03/2023 |
4
| Chen Bihua (10% Owner) has filed a Form 4 on Biomea Fusion, Inc.|
Txns:
| Bought 400,000 shares
@ $30, valued at
$12M
|
|
| 03/16/2023 |
4
| Cormorant Asset Management, LP (10% Owner) has filed a Form 4 on Ambrx Biopharma Inc.|
Txns:
| Bought 250,000 shares
@ $9.9531, valued at
$2.5M
Bought 250,000 shares
@ $10.5955, valued at
$2.6M
Bought 500,000 shares
@ $10.1485, valued at
$5.1M
|
|
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/13/2022 |
4
| Cormorant Asset Management, LP (Former 10% Owner) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Converted 616,786 shares
@ $0
Converted 616,786 convertible preferred
@ $0 |
|
| 10/27/2021 |
4
| Cormorant Asset Management, LP (Former 10% Owner) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Converted 785,303 shares
@ $0
Bought 625,000 shares
@ $16, valued at
$10M
Converted 548,288 convertible preferred
@ $0
Converted 237,015 convertible preferred
@ $0 |
|
| 10/15/2021 |
4
| Cormorant Asset Management, LP (Former 10% Owner) has filed a Form 4 on Pyxis Oncology, Inc.|
Txns:
| Converted 668,854 shares
@ $0
Bought 450,000 shares
@ $16, valued at
$7.2M
Converted 668,854 convertible preferred
@ $0 |
|
| 09/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2021 |
4
| Cormorant Asset Management, LP (Former 10% Owner) has filed a Form 4 on Icosavax, Inc.|
Txns:
| Converted 426,393 shares
@ $0
Converted 426,393 convertible preferred
@ $0 |
|
| 07/22/2021 |
4
| Chen Bihua (Director) has filed a Form 4 on Erasca, Inc.|
Txns:
| Converted 9,555,553 shares
@ $0
Bought 950,000 shares
@ $16, valued at
$15.2M
Converted 4,000,000 convertible preferred
@ $0
Converted 4,166,666 convertible preferred
@ $0
Converted 1,388,887 convertible preferred
@ $0 |
|
| 07/07/2021 |
4
| Cormorant Asset Management, LP (Former 10% Owner) has filed a Form 4 on Aerovate Therapeutics, Inc.|
Txns:
| Converted 1,530,691 shares
@ $0
Bought 500,000 shares
@ $14, valued at
$7M
Converted 1,530,691 convertible preferred
@ $0 |
|
| 07/01/2021 |
4
| Cormorant Asset Management, LP (Former 10% Owner) has filed a Form 4 on Elevation Oncology, Inc.|
Txns:
| Converted 1,983,168 shares
@ $0
Bought 250,000 shares
@ $16, valued at
$4M
Converted 1,983,168 convertible preferred
@ $0 |
|
| 06/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/22/2020 |
4
| Cormorant Asset Management, LP (Former 10% Owner) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Converted 1,492,060 shares
@ $0
Bought 800,000 shares
@ $18, valued at
$14.4M
Converted 1,492,060 convertible preferred
@ $0 |
|
| 11/23/2020 |
4
| Cormorant Asset Management, LP (Former 10% Owner) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Converted 2,845,544 shares
@ $0
Bought 425,000 shares
@ $19, valued at
$8.1M
Converted 2,122,367 convertible preferred
@ $0
Converted 723,177 convertible preferred
@ $0 |
|
| 11/05/2020 |
4
| Cormorant Asset Management, LP (Former 10% Owner) has filed a Form 4 on Atea Pharmaceuticals, Inc.|
Txns:
| Converted 6,411,355 shares
@ $0
Converted 1,000,000 convertible preferred
@ $0
Converted 1,650,165 convertible preferred
@ $0
Converted 2,631,580 convertible preferred
@ $0
Converted 712,250 convertible preferred
@ $0
Converted 417,360 convertible preferred
@ $0 |
|
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/12/2019 |
4
| Cormorant Asset Management, LP (Former 10% Owner) has filed a Form 4 on Turning Point Therapeutics, Inc. |
| 05/16/2019 |
4
| Cormorant Asset Management, LP (10% Owner) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Exercised 23,268 shares
@ $2.1945, valued at
$51.1k
Exercised 23,268 options to buy
@ $2.1945, valued at
$51.1k
|
|
| 04/25/2019 |
4
| Cormorant Asset Management, LP (10% Owner) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Bought 400,000 shares
@ $18, valued at
$7.2M
|
|
|
|
|